Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: Implication of noradrenergic and serotonergic mechanisms

Journal of Psychopharmacology

Volumn 12, Issue 4, 1998, Pages 348-355

  Redrobe, John P ^a   Bourin, Michel ^a   Colombel, Marie Claude ^a   Baker, Glen B ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Apomorphine; Clonidine; Forced swimming test; Noradrenaline; Paroxetine; Serotonin

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; APOMORPHINE; CLONIDINE; FENCLONINE; PAROXETINE; PINDOLOL; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FORCED SWIMMING TEST; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SEROTONINERGIC SYSTEM;

EID: 0031774133     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200404     Document Type: Article

References (45)

1. Armitage P, Berry G (1987) Statistical methods in medical research, 2nd edn. Blackwell, Oxford, pp. 203-205
2. Artigas F (1995) Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Archs Gen Psychiat 52: 969-971
3. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archs Gen Psychiat 51: 248-251
4. Avorn J, Everitt D E, Weiss S (1986) Increased antidepressant use in patients prescribed beta-blockers. JAMA 255: 357-360
5. Baker G B, Coutts R T, Rao T S (1987) Neuropharmacological and neurochemical properties of N-(cyanoethyl)-beta-phenylethylamine, a prodrug of beta-phenylethylamine. Br J Pharmac 92: 243-256
6. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in treatment of major depression. J Clin Psychopharmac 15: 217-222
7. Boissier J R, Simon P (1965) Action de la caféine sur la motilité spontanée de la souris. Archs Int Pharmacodyn 158: 212-221
8. Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology 94: 147-160
9. Borsini F, Nowakowska E, Samanin R (1983) Evidence that dopaminergic mechanisms are mainly involved in the antiimmobility (despair test) effect of repeated treatment with antidepressants in rats. Meeting of the Polish Pharmacological Society, Warsaw, Poland, 27th September 1983, p. 594A
10. Bourin M (1990) Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests? Fund Clin Pharmac 4: 49-64
11. Cervo L, Grignaschi G, Samanin R (1989) 1-(-3-Trifluoromethylphenyl)piperazine (TFMPP) in the ventral tegmental area reduces the effect of desipramine in the forced swimming test in rats: possible role of serotonin receptors. Eur J Pharmac 171: 119-125
12. 1B receptor. Br J Pharmacol 110: 1621-1629
13. Chojnacka-Wojcik E, Tatarczynska E, Golembiowska K, Prezegalinski E (1991) Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats. Neuropharmacology 30: 711-717
14. Creese I (1987) Biochemical properties of CNS dopamine receptors. In Meltzer H (ed.), Psychopharmacology: the third generation of progress. Raven Press, New York, pp. 257-264
15. Gardier A M, Jacquot C, Artigas F (1995) Bases neurobiologiques du role des récepteurs 5-HT1A dans le mode d'action des antidépresseurs sérotoninergiques. Synthèse 11: 1407-1417
16. Gardier A M, Malagié I, Trillat A C, Jacquot C, Artigas F (1996) Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fund Clin Pharmac 10: 16-27
17. Glennon R A, Naiman N A, Peirson M E, Titeler M, Lyon R A, Weisberg E (1988) NAN190: a arylpiperazine analog that antagonizes the stimulus effect of the 5-HT agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmac 154: 339-341
18. Gorka Z, Wojtasik E (1980) The effect of antidepressants on behavioural despair in rats. Pol J Pharmac Pharm 32: 463-468
19. Gorka Z, Zancy E (1981) The effect of single and chronic administration of imipramine on clonidine-induced hypothermia in the rat. Life Sci 28: 2847-2854
20. Hoyer D (1988) Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res 8: 59-81
21. 3H]ketanserin. Eur J Pharmacol 118: 13-23
22. Ichikawa J, Meltzer H Y (1995) Effect of antidepressants on striatal and accumbens extracellular dopamine levels. Eur J Pharmac 281: 255-261
23. Johnson A M (1989) An overview of the animal pharmacology of paroxetine. Acta Psychiat Scand 80 (Suppl. 350): 14-20
24. Kelly JP, Leonard BE (1995) The contribution of pre-clinical drug evaluation in predicting the clinical profile of the selective serotonin reuptake inhibitor paroxetine. J Ser Res 1: 27-46
25. Langer S Z (1977) Presynaptic receptors and their role in the regulation of transmitter release. Br J Pharmac 60: 481-497
26. Lassen J B (1978a) Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors. Eur J Pharmac 47: 351-358
27. Lassen J B (1978b) Influence of the new 5-HT uptake inhibitor paroxetine on hypermotility in rats produced by p-chloroamphetamine (PCA) and 4,alpha-dimethyl-m-tyramine (H77/77). Psychopharmacology 57: 151-153
28. Leonard B E (1992) Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 43 (Suppl. 2): 3-10
29. Lucki I (1989) Behavioural responses associated with serotonin receptors. In Thompson T, Dews P B, Barrett J E (eds), Advances in behavioural pharmacology. Lawrence Erlbaum, Hillsdale, NJ p. 119
30. Lucki I (1992) 5-HT1 receptors and behavior. Neurosci Biobehav Rev 16: 83-89
31. Luscombe G P, Martin K F, Hutchins L J, Gosden J, Heal D J (1993) Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Br J Pharmac 108: 669-677
32. Magnussen J, Tonder K, Engbaek F (1982) Paroxetine, a potent selective long-acting inhibitor of synaptosomal 5-HT uptake in mice. J Neural Transm 55: 217-226
33. Nixon M K, Hascoet M, Bourin M, Colombel M C (1994) Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotonergic system. Psychopharmacology 115: 59-64
34. O'Neill M F, Parameswaran T (1997) RU24969-induced behavioural syndrome requires activation of both 5-HT1A and 5-HT1B receptors. Psychopharmacology132: 255-260
35. Peroutka S J (1993) 5-Hydroxytryptamine receptors. J Neurochem 60: 408-416
36. Pilc A (1987) The role of alpha 2-adrenoreceptors in the mechanism of action of antidepressant drugs. Pol J Pharmac Pharm 39: 691-713
37. Porsolt R D, Bertin A, Jalfre M (1977) Behavioural despair in mice: a primary screening test for antidepressants. Archs Int Pharmacodyn 229: 327-336
38. Puech A J, Chermat R, Poncelet M, Doare L, Simon P (1981) Antagonism of hypothermia and behavioural response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics. Psychopharmacology 75:84-91
39. Redmond A M, Kelly J P, Leonard B E (1994) Effect of paroxetine and fluvoxamine on behavioural changes in a number of paradigms in the olfactory bulbectomised rat model of depression. J Serotonin Res 3: 199-205
40. Redrobe J P, MacSweeney C P, Bourin M (1996) The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur J Pharmac 318: 213-220
41. Routledge C, Gurling J, Ashworth-Preece M A, Dourish C T (1995) Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190. Eur J Pharmacol 276: 281-284
42. Thomas D R, Nelson D R, Johnson A M (1987) Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 93: 193-200
43. Tricklebank M D, Forler C, Fozard J R (1984) The involvement of subtypes of the 5-HT1 receptor and of the catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur J Pharmac 106: 271-282
44. Tricklebank M D, Neill J, Kidd E J, Fozard J R (1987) Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin by the putative 5-HT1 receptor. Eur J Pharmac 133: 47-56
45. Williams A R, Dourish C T (1992) Effects of the putative 5-HT1A receptor antagonist NAN-190 on free feeding and on feeding induced by the 5-HT1A receptor agonist 8-OH-DPAT in the rat. Eur J Pharmac 219: 105-112